Plasma GDF15 levels associated with circulating immune cells predict the efficacy of PD-1/PD-L1 inhibitor treatment and prognosis in patients with advanced non-small cell lung cancer

被引：0
|
作者：
Green Hong
Pureum Sun
Chaeuk Chung
Dongil Park
Song-I Lee
Nayoung Kim
Seong Eun Lee
Jeong Eun Lee
Yea Eun Kang
Da Hyun Kang
机构：
[1] Chungnam National University,Department of Internal Medicine, College of Medicine
[2] Chungnam National University,Institute for Medical Sciences, College of Medicine
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
GDF15; Non-small cell lung cancer; Immunotherapy; Survival; Biomarker; Efficacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：159 / 171
页数：12
相关论文
共 50 条
  • [1] Plasma GDF15 levels associated with circulating immune cells predict the efficacy of PD-1/PD-L1 inhibitor treatment and prognosis in patients with advanced non-small cell lung cancer
    Hong, Green
    Sun, Pureum
    Chung, Chaeuk
    Park, Dongil
    Lee, Song-, I
    Kim, Nayoung
    Lee, Seong Eun
    Lee, Jeong Eun
    Kang, Yea Eun
    Kang, Da Hyun
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (01) : 159 - 171
  • [2] Correlation of Lung Immune Prognostic Index With Efficacy of PD-1/PD-L1 Inhibitor Combined With Chemotherapy and Prognosis in Patients With Advanced Non-Small Cell Lung Cancer
    Zhu, Zhongxiu
    Zhang, Aixia
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2023, 46 (11): : 496 - 502
  • [3] Efficacy and safety of PD-1/PD-L1 inhibitors in elderly patients with advanced non-small cell lung cancer
    Li, Li
    Xu, Chunhua
    Wang, Wei
    Zhang, Qian
    CLINICAL RESPIRATORY JOURNAL, 2024, 18 (05)
  • [4] Resistance to PD-1/PD-L1 immune checkpoint blockade in advanced non-small cell lung cancer
    Li, Lijun
    Pu, Haihong
    Zhang, Xiaoxin
    Guo, Xiaotian
    Li, Guangrui
    Zhang, Minghui
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2025, 209
  • [5] Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab
    Nicolazzo, Chiara
    Raimondi, Cristina
    Mancini, MariaLaura
    Caponnetto, Salvatore
    Gradilone, Angela
    Gandini, Orietta
    Mastromartino, Maria
    del Bene, Gabriella
    Prete, Alessandra
    Longo, Flavia
    Cortesi, Enrico
    Gazzaniga, Paola
    SCIENTIFIC REPORTS, 2016, 6
  • [6] Circulating Suppressive Immune Cells Predict the Efficacy of Anti PD-1 Immunotherapy in Patients with Advanced Non-Small Cell Lung Cancer
    Koh, J.
    Kim, Y.
    Lee, K. Y.
    Kim, M. S.
    Ku, B. M.
    Sun, J.
    Lee, S.
    Ahn, J. S.
    Park, K.
    Ahn, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S448 - S449
  • [7] PD-1/PD-L1 Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
    Bagley, Stephen J.
    Bauml, Joshua M.
    Langer, Corey J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (10) : 676 - 683
  • [8] PD-1/PD-L1 interaction score and NKT-like cell infiltration predict immunotherapy efficacy in non-small cell lung cancer patients
    Zhang, Jing
    Lin, Dong
    Hu, Huihua
    Xu, Haipeng
    CYTOTHERAPY, 2024, 26 (12) : 1484 - 1490
  • [9] Targeting the PD-1/PD-L1 axis in non-small cell lung cancer
    Kumar, Rajiv
    Collins, Dearbhaile
    Dolly, Saoirse
    McDonald, Fiona
    O'Brien, Mary E. R.
    Yap, Timothy A.
    CURRENT PROBLEMS IN CANCER, 2017, 41 (02) : 111 - 124
  • [10] Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors
    Kang, Da Hyun
    Park, Cheol-Kyu
    Chung, Chaeuk
    Oh, In-Jae
    Kim, Young-Chul
    Park, Dongil
    Kim, Jinhyun
    Kwon, Gye Cheol
    Kwon, Insun
    Sun, Pureum
    Shin, Eui-Cheol
    Lee, Jeong Eun
    IMMUNE NETWORK, 2020, 20 (03) : 1 - 11
12345